China Life Science Investment Co. Ltd., Doublle Bioproducts Inc., Mologen Holding AG deal

Doublle will perform preclinical testing of gene-modified and immunomodulated tumor cells provided by Mologen with the aim of developing a gene therapy to treat cancer. China Life Science will supply ...